Showing results (681-690 of 1,533) with videos related to

Sort By:
Pageof 154
One Health (Amsterdam, Netherlands)|March 4, 2025
Zoonotic tuberculosis in Catalonia, Spain: Phylogenetic insights into Mycobacterium bovis and M. caprae transmission at the human-livestock interfaceBernat Pérez de Val, Enric Vidal, Tod Stuber, et al.
Journal of Food Protection|June 12, 2010
Selection and characterization of cellulose-deficient derivates of shiga toxin-producing Escherichia coliByong Kwon Yoo, Tod Stewart, Jean Guard-Bouldin, et al.
Infection and Immunity|March 14, 2007
Murine aerosol challenge model of anthraxCrystal L Loving, Mary Kennett, Gloria M Lee, et al.
Molecular Pharmacology|May 5, 2007
A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptorTod Steinfeld, Mathai Mammen, Jacqueline A M Smith, et al.
Journal of Nursing Management|June 6, 2020
Advanced practice nurses' experiences and well-being: Baseline demographics from a cohort studyEmily Wood, Rachel King, Steve Robertson, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 29, 2022
Moral distress in advanced practice nurses during the COVID-19 pandemicEmily Wood, Rachel King, Bethany Taylor, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 15, 2007
Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J miceKaren K Szumlinski, Alexis W Ary, Kevin D Lominac, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovirF De Bony, M Tod, R Bidault, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
A pharmacodynamic model of ganciclovir antiviral effect and toxicity for lymphoblastoid cells suggests a new dosing regimen to treat cytomegalovirus infectionAudrey Janoly-Dumenil, Isabelle Rouvet, Nathalie Bleyzac, et al.
Fundamental & Clinical Pharmacology|January 31, 2012
How to solve the problem of spontaneous bacterial clearance when testing new antibiotic treatment: results on experimental pneumonia due to a derepressed cephalosporinase-producing Enterobacter cloacaeAnne Jacolot, Claire Judel, Kamel Louchahi, et al.
Pageof 154